Real‐life efficacy and safety of vemurafenib plus rituximab in relapsed or refractory hairy‐cell leukemia: A multicenter Italian retrospective study (HCL‐PG03R)
Luca De Carolis, Monia Capponi, Andrea Bernardelli, Andrea Visentin, Gianna Maria D'Elia, Simone Ferrero, Michele Cimminiello, Azzurra Romeo, Barbara Pocali, Luciana Morino, Alessandro Sanna, Ombretta Annibali, Francesca Ricci, Flavio Falcinelli, Alessandro Mancini
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsChronic Lymphocytic Leukemia Research · Chronic Myeloid Leukemia Treatments · Retinoids in leukemia and cellular processes